This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
We are delighted to extend our heartfelt gratitude to all participants of the International Alzheimer’s Disease & Dementia Conference (Dementia 2022), which was virtually hosted by Magnus Group on June 15-16, 2022. The conference, centered around the theme “Explicating Advancements to Combat the Silent Epidemic of Dementia and Alzheimer,” was a resounding success. Together, we presented hope through fresh research, information, and innovative treatments related to Alzheimer’s and dementia. Thank you for your valuable contributions and for making Dementia 2022 a memorable and impactful event.
Important Alert:
X
Title : Can we stimulate neuroplasticity with the cell signaling molecule ghrelin?
Irina Stoyanova, Medical University of Varna, Bulgaria
Title : Sleep quality improvement for Alzheimer’s disease
Benyi Li, University of Kansas, United States
Title : Breakthrough in Dementia
Esther Ebenezer, UniKL Royal College of Medicine Perak, Malaysia
Title : Implications for Serum Amyloid P in the Pathogenesis of Alzheimer’s Disease
Mark S Kindy, University of South Florida and the James A. Haley VA Hospital, United States
Title : Memory decline in dementia and its impact on spoken spontaneous discourse production
Anthony Pak-Hin Kong, The University of Hong Kong, Hong Kong
Title : Brain insulin resistance in Alzheimer’s disease: can phytochemicals exert beneficial effects?
Mario Allegra, University of Palermo, Italy